Institutional Ownership
Crispr Therapeutics AG
CUSIP H17182108NAMEN AKTCRSPQ1 2026
Institutional Holders
478
13F filers
Shares Held
74.62M
Aggregate institutional
Institutional Value
$3.37B
Q1 2026
Net New Holders
+11
67 new · 56 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions67
Increased176
Decreased115
Sold out56
Institutional Holders
478 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Ark Investment Management LLC | 11.31M | $538.19M | +791.6K | Added |
| 2 | Blackrock, Inc. | 7.68M | $365.34M | +171.9K | Added |
| 3 | Orbis Allan Gray Ltd | 6.11M | $290.46M | +155.9K | Added |
| 4 | Capital World Investors | 4.73M | $224.77M | +4.73M | New |
| 5 | State Street Corp | 3.98M | $189.45M | +229.1K | Added |
| 6 | Gsk PLC | 3.22M | $153.21M | 0 | Held |
| 7 | Geode Capital Management, LLC | 2.38M | $113.10M | +127.9K | Added |
| 8 | Sr One Capital Management, LP | 2.04M | $96.98M | 0 | Held |
| 9 | Fmr LLC | 1.95M | $92.98M | +737 | Added |
| 10 | Sumitomo Mitsui Trust Group, Inc. | 1.85M | $88.19M | −104.2K | Reduced |
468 more institutional holders on Premium
See every fund holding Crispr Therapeutics AG, with full quarter-over-quarter share changes.
Unlock all holders